NASDAQ · YB

Yuanbao Inc.. American

$14.18 +$0.86 (+6.46%) 1D Market open

Key Metrics

$613.79M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $1.48B
Beta · 1Y 0.74
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 10
    The stock moved +15.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 10
  • May 26
    From its Feb 17 high, the share price fell 41%.

    Peak close $20.85 on Feb 17; trough close $12.37 on May 26. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -41%
  • Mar 19
    The stock moved -14.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$613.79M
Enterprise value
Shares outstanding46.1M
52-wk range$12.01 – $30.50
Avg volume · 20D65.8K
Net cash
Book value / share$72.62
ExchangeNASDAQ
About Yuanbao Inc.. American
IPO dateApr 30, 2025
Employees613

Yuanbao Inc is a technology-driven online insurance distributor in China. Its engine enables the company to provide customized services for each insurance consumer across personalized recommendation, purchasing, policy management, claim settlements, and post-sale services.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF0.42
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio3.91
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$3.32B

Cash Flow · TTM

Operating CF $1.50B
Capex −$19.04M
Free cash flow $1.48B
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings